Qichao Hu

1.5k total citations · 2 hit papers
43 papers, 1.0k citations indexed

About

Qichao Hu is a scholar working on Molecular Biology, Epidemiology and Pharmacology. According to data from OpenAlex, Qichao Hu has authored 43 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 13 papers in Epidemiology and 13 papers in Pharmacology. Recurrent topics in Qichao Hu's work include Cancer-related molecular mechanisms research (7 papers), Liver Disease Diagnosis and Treatment (7 papers) and Drug Transport and Resistance Mechanisms (6 papers). Qichao Hu is often cited by papers focused on Cancer-related molecular mechanisms research (7 papers), Liver Disease Diagnosis and Treatment (7 papers) and Drug Transport and Resistance Mechanisms (6 papers). Qichao Hu collaborates with scholars based in China, Germany and Canada. Qichao Hu's co-authors include Xiao Ma, Yanling Zhao, Jinhao Zeng, Wenwen Zhang, Xinyu Deng, Xi Peng, Yinxiao Jiang, Xiaolin Xiao, Yuan Chen and Shizhang Wei and has published in prestigious journals such as International Journal of Cancer, Molecules and Pharmacology & Therapeutics.

In The Last Decade

Qichao Hu

41 papers receiving 1.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Baicalin and the liver-gut system: Pharmacological bases explaining its therapeutic effects

2021 171 citations Qichao Hu, Wenwen Zhang et al. Pharmacological Research profile →
Diabetic nephropathy: Focusing on pathological signals, clinical treatment, and dietary regulation

2023 99 citations Qichao Hu, Yuan Chen et al. profile →

Peers

Countries citing papers authored by Qichao Hu

Since Specialization

Citations

This map shows the geographic impact of Qichao Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qichao Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qichao Hu more than expected).

Fields of papers citing papers by Qichao Hu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qichao Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qichao Hu. The network helps show where Qichao Hu may publish in the future.

Co-authorship network of co-authors of Qichao Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Qichao Hu. A scholar is included among the top collaborators of Qichao Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qichao Hu. Qichao Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Exploration of the Combined Mechanism of Direct and Indirect Effects of Paeoniflorin in the Treatment of Cholestasis 2025 ·Inflammation ·(unknown), (unknown), Rong Sun, Yi Zeng, (unknown), Qichao Hu, Sam Li‐Sheng Chen, Xiao Ma, (unknown), Yanling Zhao	0
2	Gasdermins family-mediated cell survival: exploration of natural products intervention mechanisms 2025 ·Phytomedicine ·Wenwen Zhang, Jing Yan, (unknown), Yi Zeng, Rong Sun, Qichao Hu, (unknown), Xiao Ma, Yanling Zhao, Jinhao Zeng	1
3	Daidzein alleviates ethanol-induced acute gastric injury in rats by targeting ESR1 and activating the PI3K/AKT/CREB signaling pathway 2025 ·Phytomedicine ·Tao Jiang, S. X. Du, (unknown), Qichao Hu, (unknown), Yuan Chen, Xiaohua Tan, Yi Zeng, (unknown), (unknown), Kun Xiao, Xiao Ma, Jinhao Zeng, Yanling Zhao	2
4	Targeting ICAM1/ITGB2 with plumbagin preserves intercellular adhesion and attenuates gastric precancerous lesions 2025 ·Phytomedicine ·Maoyuan Zhao, Yi Yang, (unknown), (unknown), Heng Yang, Qichao Hu, (unknown), (unknown), Xiao Ma, Jinhao Zeng, Thomas Efferth	2
5	Role of gut microbiota and fecal metabolites in the protective effect of soybean pulp-rich diet against estrogen-induced cholestasis in rats 2025 ·Current Research in Food Science ·(unknown), Qichao Hu, (unknown), Liwei Lang, Shizhang Wei, Haotian Li, Manyi Jing, Xiao Ma, Yanling Zhao, Xuelin Zhou	0
6	Paeoniflorin inhibited GSDMD to alleviate ANIT-induced cholestasis via pyroptosis signaling pathway 2024 ·Phytomedicine ·(unknown), Wenwen Zhang, (unknown), Qichao Hu, (unknown), Tao Jiang, Yi Zeng, Thomas Efferth	9
7	Paeoniflorin protects hepatocytes from APAP-induced damage through launching autophagy via the MAPK/mTOR signaling pathway 2024 ·Cellular & Molecular Biology Letters ·Xinyu Deng, Yubing Li, Yuan Chen, Qichao Hu, Wenwen Zhang, Lisheng Chen, Xiaohua Lu, Jinhao Zeng, Xiao Ma, Thomas Efferth	33
8	Chidan Tuihuang granule modulates gut microbiota to influence NOD1/RIPK2 pathway in cholestatic liver injury recovery 2024 ·Phytomedicine ·(unknown), Qichao Hu, Wenwen Zhang, (unknown), Yan Jin, (unknown), (unknown), Xiao Ma, (unknown), Xiaohua Lu, Thomas Efferth	1
9	Flavonoids and Gastric Cancer Therapy: From Signaling Pathway to Therapeutic Significance 2024 ·Drug Design Development and Therapy ·(unknown), (unknown), Qichao Hu, Huafeng Pan, Maoyuan Zhao, (unknown), Jinhao Zeng, Xiao Ma, (unknown)	16
10	Dehydroevodiamine targeting IKKβ to alleviate acute gastric injury via inhibiting the p65/NLRP3 axis 2024 ·Phytomedicine ·Qichao Hu, Yuan Chen, Wenwen Zhang, Yubing Li, Xinyu Deng, Lisheng Chen, (unknown), Xiao Ma, Jinhao Zeng, Yanling Zhao	5
11	Natural products targeting signaling pathways associated with regulated cell death in gastric cancer: Recent advances and perspectives 2023 ·Phytotherapy Research ·Qichao Hu, (unknown), (unknown), Xinyu Deng, Yuan Chen, Xiao Ma, Jinhao Zeng, Yanling Zhao	14
12	Human diet‐derived polyphenolic compounds and hepatic diseases: From therapeutic mechanisms to clinical utilization 2023 ·Phytotherapy Research ·Qichao Hu, Wenwen Zhang, (unknown), (unknown), (unknown), Dan Song, Jianxia Wen, Jun-Dong Wang, Qing Nian, Xiao Ma, Jinhao Zeng, Yanling Zhao	13
13	Metabolomics Profiles Reveal the Efficacy of Wuzhuyu Decoction on Patients with Chronic Non-Atrophic Gastritis 2023 ·Drug Design Development and Therapy ·Qichao Hu, Jinhao Zeng, Xiaomei Zhang, Tingting He, (unknown), (unknown), Shizhang Wei, Manyi Jing, Haotian Li, (unknown), Lei Chang, Xiao Ma, Yanling Zhao	5
14	Bidirectional effects of geniposide in liver injury: Preclinical evidence construction based on meta-analysis 2023 ·Journal of Ethnopharmacology ·(unknown), (unknown), Simiao Liu, Qichao Hu, Sihan Hu, Jinhao Zeng, Xiao Ma, Xiaomei Zhang	18
15	Deciphering the toxicity-effect relationship and action patterns of traditional Chinese medicines from a smart data perspective: a comprehensive review 2023 ·Frontiers in Pharmacology ·Yubing Li, Xinyu Deng, Huiling Xiong, Qichao Hu, Yuan Chen, Wenwen Zhang, Xiao Ma, Yanling Zhao	6
16	Evidence construction of Huangkui capsule against chronic glomerulonephritis: A systematic review and network pharmacology 2022 ·Phytomedicine ·(unknown), Xixi Chen, (unknown), (unknown), Qichao Hu, Xiaolin Xiao, (unknown), Jinhao Zeng, Xiao Ma	11
17	Differential Expression Profiles of lncRNA Following LPS-Induced Inflammation in Bovine Mammary Epithelial Cells 2021 ·Frontiers in Veterinary Science ·Jinpeng Wang, Qichao Hu, Jian Yang, Zhuoma Luoreng, Xinping Wang, (unknown), Dawei Wei	10
18	Tripterygium hypoglaucum (Lévl.) Hutch and Its Main Bioactive Components: Recent Advances in Pharmacological Activity, Pharmacokinetics and Potential Toxicity 2021 ·Frontiers in Pharmacology ·(unknown), Fangling Zhang, Xiaolin Xiao, Zhao Wu, Qichao Hu, Yinxiao Jiang, Wenwen Zhang, Shizhang Wei, Xiao Ma, Xiaomei Zhang	36
19	Baicalin and the liver-gut system: Pharmacological bases explaining its therapeutic effects breakdown → 2021 ·Pharmacological Research ·Qichao Hu, Wenwen Zhang, Zhao Wu, Xin Tian, (unknown), Longxuan Li, Zhihao Li, Xi Peng, Shizhang Wei, Xiao Ma, Yanling Zhao	171
20	Donor Graft MicroRNAs: A Newly Identified Player in the Development of New-onset Diabetes After Liver Transplantation 2016 ·American Journal of Transplantation ·Qi Ling, Haiyang Xie, Jun Li, (unknown), Jingli Cao, Fan Yang, (unknown), Qichao Hu, Xiao Xu, Shusen Zheng	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact